Keywords
Last Name
Institution

Charles Lumpkin

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPediatrics, College of Medicine
DivisionPeds Endocrinology
Address ACH Research Institute
1120 Marshall Street
Mail Slot # 512-6
Little Rock AR 72202
Phone501-364-2797
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUniversity of Arkansas for Medical Sciences
    DepartmentPathology, College of Medicine


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Thrailkill KM, Bunn RC, Nyman JS, Rettiganti MR, Cockrell GE, Wahl EC, Uppuganti S, Lumpkin CK, Fowlkes JL. Corrigendum to "SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice" [Bone 82 (2016) 101-107]. Bone. 2016 Nov 29. PMID: 27913134.
      View in: PubMed
    2. Thrailkill KM, Nyman JS, Bunn RC, Uppuganti S, Thompson KL, Lumpkin CK, Kalaitzoglou E, Fowlkes JL. The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes. Bone. 2017 Jan; 94:141-151. PMID: 27989651.
      View in: PubMed
    3. Stine KC, Wahl EC, Liu L, Skinner RA, VanderSchilden J, Bunn RC, Montgomery CO, Aronson J, Becton DL, Nicholas RW, Swearingen CJ, Suva LJ, Lumpkin CK. Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity. J Orthop Res. 2016 Oct; 34(10):1716-1724. PMID: 26867804.
      View in: PubMed
    4. Thrailkill KM, Clay Bunn R, Nyman JS, Rettiganti MR, Cockrell GE, Wahl EC, Uppuganti S, Lumpkin CK, Fowlkes JL. SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice. Bone. 2016 Jan; 82:101-7. PMID: 26211996.
      View in: PubMed
    5. Fowlkes JL, Nyman JS, Bunn RC, Cockrell GE, Wahl EC, Rettiganti MR, Lumpkin CK, Thrailkill KM. Effects of long-term doxycycline on bone quality and strength in diabetic male DBA/2J mice. Bone Rep. 2015 Jan; 1:16-19. PMID: 25685827.
      View in: PubMed
    6. Thrailkill K, Bunn RC, Lumpkin C, Wahl E, Cockrell G, Morris L, Kahn CR, Fowlkes J, Nyman JS. Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone. J Diabetes Res. 2014; 2014:703589. PMID: 24963495; PMCID: PMC4052184.
    7. Stine KC, Wahl EC, Liu L, Skinner RA, Vanderschilden J, Bunn RC, Montgomery CO, Suva LJ, Aronson J, Becton DL, Nicholas RW, Swearingen CJ, Lumpkin CK. Cisplatin inhibits bone healing during distraction osteogenesis. J Orthop Res. 2014 Mar; 32(3):464-70. PMID: 24259375; PMCID: PMC4080883.
    8. Mercer KE, Sims CR, Yang CS, Wynne RA, Moutos C, Hogue WR, Lumpkin CK, Suva LJ, Chen JR, Badger TM, Ronis MJ. Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice. Alcohol Clin Exp Res. 2014 Mar; 38(3):672-82. PMID: 24256560; PMCID: PMC4068959.
    9. Fowlkes JL, Nyman JS, Bunn RC, Jo C, Wahl EC, Liu L, Cockrell GE, Morris LM, Lumpkin CK, Thrailkill KM. Osteo-promoting effects of insulin-like growth factor I (IGF-I) in a mouse model of type 1 diabetes. Bone. 2013 Nov; 57(1):36-40. PMID: 23886838; PMCID: PMC3789626.
    10. Nyman JS, Bunn RC, Thrailkill KM, Lumpkin CK Jr, Wahl EC, Cockrell GE, Clark LM, Fowlkes JL. Loss of insulin signaling in osteoprogenitor cells impairs structural strength of bone without affecting glucose and insulin metabolism. 42nd International Sun Valley Workshop on Skeletal Tissue Biology. 2013.
    11. Nyman JS, Bunn RC, Thrailkill KT, Lumpkin CK Jr, Wahl EC, Cockrell G, Clark LM, Fowlkes JL. Loss of insulin signaling in osteoprogenitor cells impairs structural strength of bone. ABI. 2013.
    12. Mercer KE, Wynne RA, Lazarenko OP, Lumpkin CK, Hogue WR, Suva LJ, Chen JR, Mason AZ, Badger TM, Ronis MJ. Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther. 2012 Nov; 343(2):401-12. PMID: 22892342; PMCID: PMC3477212.
    13. Wahl, EC, Aronson, J, Liu, L, Skinner, RA, Miller, MJ, Fowlkes, JL, Ronis, MJJ, Lumpkin CK. Direct bone formation during distraction osteogenesis in TNF receptor 1 deficient Mice is protected from the negative effects of chronic ethanol. Alcohol. 2012; 46(2):133-138.
    14. Mercer K, Wynne RA, Lazarenko OP, Lumpkin CK, Hogue WR, Suva L, Chen J-R, Mason AZ, Badger TM, Ronis MJJ. Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in the female rat. J Pharmacol Exp Ther. 2012; 343:401-412.
    15. Lumpkin CK Jr, Wahl EC, Aronson J, Liu L, Skinner RA, Ronis MJJ. Metabolic Endotoxemia and Inhibition of Direct Bone Regeneration. Brit J Med Med. 2012; 2:510-519.
    16. Wahl EC, Aronson J, Liu L, Skinner RA, Ronis MJ, Lumpkin CK. Distraction osteogenesis in TNF receptor 1 deficient mice is protected from chronic ethanol exposure. Alcohol. 2012 Mar; 46(2):133-8. PMID: 21908154; PMCID: PMC3275664.
    17. Fowlkes JL, Bunn RC, Cockrell GE, Clark LM, Wahl EC, Lumpkin CK, Thrailkill KM. Dysregulation of the intrarenal vitamin D endocytic pathway in a nephropathy-prone mouse model of type 1 diabetes. Exp Diabetes Res. 2011; 2011:269378. PMID: 21747824; PMCID: PMC3123992.
    18. Mercer K, Wynne R, Moutos C, Lumpkin C, Suva L, Badger T, Chen JR, Ronis MJ. Alcohol induced bone loss is blocked in p47 phox -/- mice lacking functional NADPH oxidases. Soc Toxicology, 2011. 2011.
    19. Fowlkes J, Nyman J, Jo C, Wahl E, Liu L, Cockrell G, Clark L, Lumpkin C, Thrailkill K. Osteopromoting effects of rhIGF-I in a mouse model of type 1 diabetes. 93rd Endocrine Soc, 2011. 2011.
    20. Suva L, Stine K, Wahl E, Liu L, Aronson J, Skinner R, Thrailkill K, Montgomery C, Fowlkes J, Becton D, Lumpkin C. Cisplatin treatment inhibits bone healing: implications for osteosarcoma surgery. American Soc Bone Miner Res. 2011.
    21. Fleming N, Williams DM, Eischen C, Lumpkin C, Perrien DS. P53 is required for TNF alpha to inhibit osteoblast proliferation and differentiation. ASBMR. 2011.
    22. Nyman JS, Even JL, Jo CH, Herbert EG, Murry MR, Cockrell GE, Wahl EC, Bunn RC, Lumpkin CK, Fowlkes JL, Thrailkill KM. Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone. 2011 Apr 01; 48(4):733-40. PMID: 21185416; PMCID: PMC3062641.
    23. Chen JR, Lazarenko OP, Shankar K, Blackburn ML, Lumpkin CK, Badger TM, Ronis MJ. Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther. 2011 Mar; 336(3):734-42. PMID: 21098090; PMCID: PMC3061541.
    24. Bunn RC, Cockrell GE, Ou Y, Thrailkill KM, Lumpkin CK, Fowlkes JL. Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiovasc Diabetol. 2010 Nov 05; 9:73. PMID: 21054880; PMCID: PMC2988002.
    25. Wahl, EC, Aronson, J, Liu, L, Skinner, RA, Miller, MJ, Bunn, RC, Fowlkes, JL, Thrailkill, KM, Badger, TM, Ronis, MJ, Lumpkin CK. Direct bone formation during distraction osteogenesis does not require TNF a receptors and elevated serum TNF fails to inhibit bone formation in TNFR1 deficient mice. Bone. 2010; 46(2):410-417.
    26. Thrailkill KM, Moreau CS, Cockrell GE, Jo CH, Bunn RC, Morales-Pozzo AE, Lumpkin CK, Fowlkes JL. Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine. 2010 Apr; 37(2):336-43. PMID: 20960272; PMCID: PMC2959192.
    27. Wahl EC, Aronson J, Liu L, Fowlkes JL, Thrailkill KM, Bunn RC, Skinner RA, Miller MJ, Cockrell GE, Clark LM, Ou Y, Isales CM, Badger TM, Ronis MJ, Sims J, Lumpkin CK. Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res. 2010 Jan; 25(1):114-23. PMID: 19580462; PMCID: PMC3153322.
    28. Stine K, Wahl E, Liu L, Aronson J, Suva LJ, Becton DL, Lumpkin C. The effects of Cisplatin (CDP) administration on a mouse model of bone regeneration. Conn Tissue Oncology Soc 16th Ann Mtg,. 2010.
    29. Wahl EC, Aronson J, Liu L, Skinner RA, Miller MJ, Cockrell GE, Fowlkes JL, Thrailkill KM, Bunn RC, Ronis MJ, Lumpkin CK. Direct bone formation during distraction osteogenesis does not require TNFalpha receptors and elevated serum TNFalpha fails to inhibit bone formation in TNFR1 deficient mice. Bone. 2010 Feb; 46(2):410-7. PMID: 19772956; PMCID: PMC2818239.
    30. Shankar K, Hidestrand M, Liu X, Chen JR, Haley R, Perrien DS, Skinner RA, Lumpkin CK, Badger TM, Ronis MJ. Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats. J Bone Miner Res. 2008 Mar; 23(3):338-49. PMID: 17967133.
      View in: PubMed
    31. Fowlkes J, Nyman J, Bunn R, Cockrell G, Wahl EC, Lumpkin C. Differential effects of diabetes on the cortical vs trabecular bone compartments in two inbred mouse strains. 38th International Sun Valley Workshop on Skeletal Tissue Biology. 2008.
    32. Thrailkill K, Bunn R, Wahl E, Liu L, Fowlkes J, Lumpkin C. Insulin sufficiency vs glycemic control: relative contributions to bone formation. 90th Endocrine Soc. 2008.
    33. Thrailkill, KM, Bunn, RC, Wahl, EC, Liu, L, Fowlkes, JL, Lumpkin CK. Insulin sufficiency vs glycemic control: relative contributions to bone formation. 90th Endocrine Society. 2008.
    34. Bunn, RC, Yang, O, Cockrell, G, Thrailkill, KM, Lumpkin CK, Fowlkes, JL. Insulin augments palmitate induced cytokine production in human monocytes. American Diabetes Association. 2008.
    35. Fowlkes, JL, Nyman, J, Bunn, RC, Cockrell, G, Wahl, EC, Lumpkin CK, Thrailkill, KM. Differential effects of diabetes on the cortical vs trabecular bone compartments in two inbred mouse strains. 38th International Sun Valley Workship on Skeletal Tissue Biology. 2008.
    36. Thrailkill, KM, Bunn, RC, Coleman, HN, Cockrell GE, Wahl, EC, Lumpkin CK, Fowlkes, JL. Matrix Metalloproteinase dysregulation in an animal model of diabetic nephropathy. 90th Endocrine Society. 2008.
    37. Thrailkill K, Bunn R, Coleman H, Cockrell G, Wahl E, Lumpkin C, Fowlkes J. Matrix metalloproteinase dysregulation in an animal model of diabetic nephropathy. 90th Endocrine Soc. 2008.
    38. Bunn RC, Yang O, Cockrell G, Thrailkill KM, Lumpkin C, Fowlkes J. Insulin augments palmitate induced cytokine production in human monocytes. American Diabetes Assoc. 2008.
    39. Fowlkes JL, Bunn RC, Liu L, Wahl EC, Coleman HN, Cockrell GE, Perrien DS, Lumpkin CK, Thrailkill KM. Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology. 2008 Apr; 149(4):1697-704. PMID: 18162513; PMCID: PMC2276714.
    40. Wahl EC, Aronson J, Liu L, Liu Z, Perrien DS, Skinner RA, Badger TM, Ronis MJ, Lumpkin CK. Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis. Toxicol Appl Pharmacol. 2007 May 01; 220(3):302-10. PMID: 17391719; PMCID: PMC1892174.
    41. Liu Z, Aronson J, Wahl EC, Liu L, Perrien DS, Kern PA, Fowlkes JL, Thrailkill KM, Bunn RC, Cockrell GE, Skinner RA, Lumpkin CK. A novel rat model for the study of deficits in bone formation in type-2 diabetes. Acta Orthop. 2007 Feb; 78(1):46-55. PMID: 17453392.
      View in: PubMed
    42. Nicks, KM, Perrien, DS, Akel, NS, Suva, LJ, Lumpkin CK, Aronson, J, Gaddy, D. Acute nicotine exposure impairs the early period of fracture healing but enhances osteogenesis in bone marrow cultures through a BMP independent pathway. 6th Annual Conference of the International Society for the Prevention of Tobacco Induced Disease. 2007.
    43. Wahl, EC, Aronson, J, Liu, L, Skinnner, RA, Miller, MJ, Fowlkes, JL, Ronis, MJJ, Lumpkin CK. Direct bone formation during distraction osteogenesis does not requre TNF receptors and elevated serum TNF fails to inhibit bone format in TNFR1 deficient mice. Journal Musculoskelet Neuronal Interact. 2007.
    44. Wahl, EC, Aronson, J, Liu, L, Skinner, RA, Miller, MJ, Fowlkes, JL, Ronis, MJJ, Lumpkin CK. Direct bone formation during distraction osteogenesis does not requre TNF receptors and elevated serum TNF fails to inhibit bone format in TNFR1 deficient mice. J Musculoskelet Neuronal Interact. 2007; 13:abs.
    45. Wahl, EC, Aronson, J, Liu, L, Skinner, RA, Miller, MJ, Fowlkes, JL, Thrailkill, KM, Badger, TM, Ronis, MJJ, Sims, J, Lumpkin CK. Restoration of regenerative osteoblastogenesis in aged mice. J Bone Miner Res. 2007.
    46. Chen J-R, Shankar, K, Liu, X, Nagarajan, S, Chen, Y, Lumpkin CK, Badger, TM, Ronis, MJJ. Inhibition of reactive oxyen species generation and downstream activation of the ERK/SAT3/RANKL signaling cascade in osteoblasts accounts for the protective effects of estradiol on ethanol-induced bone loss. Endocrine Society 2007. 2007.
    47. Chen, J-R, Shankar, K, Liu, X, Nagarajan, S, Chen, Y, Lumpkin CK, Badger, TM, Ronnis, MJJ. Inhibition of reactive oxyen species generation and downstream activation of the ERK/SAT3/RANKL signaling cascade in osteoblasts accounts for the protective effects of estradiol on ethanol-induced bone loss. Endocrine Society 2007. 2007.
    48. Wahl, EC, Aronson, J, Liu, L, Skinner, RA, Miller, MJ, Fowlkes, JL, Thrailkill, KM, Badger, TM, Ronis MJJ, Sims, J, Lumpkin CK. Restoration of regenerative osteoblastogenesis in aged mice. J Bone Miner Res. 2007.
    49. Wahl EC, Liu L, Perrien DS, Aronson J, Hogue WR, Skinner RA, Hidestrand M, Ronis MJ, Badger TM, Lumpkin CK. A novel mouse model for the study of the inhibitory effects of chronic ethanol exposure on direct bone formation. Alcohol. 2006 Jul; 39(3):159-67. PMID: 17127135.
      View in: PubMed
    50. Chen JR, Haley RL, Hidestrand M, Shankar K, Liu X, Lumpkin CK, Simpson PM, Badger TM, Ronis MJ. Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts. J Pharmacol Exp Ther. 2006 Dec; 319(3):1182-90. PMID: 16971503.
      View in: PubMed
    51. Fowlkes JL, Thrailkill KM, Liu L, Wahl EC, Bunn RC, Cockrell GE, Perrien DS, Aronson J, Lumpkin CK. Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model. J Bone Miner Res. 2006 Sep; 21(9):1359-66. PMID: 16939394; PMCID: PMC2424402.
    52. Ronis, MJJ, Chen, J-R, Haley, R, Shankar, K, Hidestrand, M, Lumpkin CK. The role of reduced plasma estradiol adn impaired estrogen signaling in alcohol-induced bone loss. ISBRA World Congress and Alcohol Res. 2006.
    53. Bunn, RC, Thrailkill, KM, Liu, L, Wahl, EC, Cockrell, G, Lumpkin, CK, Fowlkes, JL. Insulin effects on de novo bone formation and osteogenic gene expression in vivo using a streptozotocin-induced diabetic mouse model and distraction osteogenesis. J Musculoskelet Neuronal Interact. 2006; 12:abc.
    54. Shankar, K, Hidestrand, M, Liu, X, Chen, J-R, Perrien, D, Skinner, RA, Lumpkin CK, Badger, TM, Ronis, MJJ. Ethanol-induced inhibition of anabolic rebuilding in post-weaning rats involves increased oxidative stress andTNF alpha in rats fed via total enteral nutrition. Endocrine Society 2006. 2006.
    55. Bunn, R.C., Thrailkill, KM, Liu, L, Wahl, EC, Cockrell, G, Lumpkin, CK, Fowlkes, JL. Insulin effects on de novo bone formation and osteogenic gene expression in vivo using a streptozotocin-induced diabetic mouse model and distraction osteogenesis. J Musculoskelet Neuronal Interact. 2006; 12:abc.
    56. Ronis, MJJ, Chen J-R, Haley, R, Shankar, K, Hidestrand, M, Lumpkin CK, Badger, Tm. The role of reduced plasma estradiol and impaired estrogen signaling in alcohol-induced bone loss. ISBRA World Congress and Alcohol Res. 2006.
    57. Thrailkill KM, Lumpkin CK, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab. 2005 Nov; 289(5):E735-45. PMID: 16215165; PMCID: PMC2387001.
    58. Shankar K, Hidestrand M, Haley R, Skinner RA, Hogue W, Jo CH, Simpson P, Lumpkin CK, Aronson J, Badger TM, Ronis MJ. Different molecular mechanisms underlie ethanol-induced bone loss in cycling and pregnant rats. Endocrinology. 2006 Jan; 147(1):166-78. PMID: 16239303.
      View in: PubMed
    59. Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, Skinner RA, Hogue WR, Carver AA, Fowlkes JL, Aronson J, Lumpkin CK. Bone formation is impaired in a model of type 1 diabetes. Diabetes. 2005 Oct; 54(10):2875-81. PMID: 16186388.
      View in: PubMed
    60. Wahl EC, Perrien DS, Aronson J, Liu Z, Fletcher TW, Skinner RA, Feige U, Suva LJ, Badger TM, Lumpkin CK. Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis. Alcohol Clin Exp Res. 2005 Aug; 29(8):1466-72. PMID: 16131855.
      View in: PubMed
    61. Fowlkes, JL, Liu, L, Wahl, EC, Bunn, RC, Thrailkill, KM, Lumpkin CK. The effects of local administration on rhIGF-I on new bone formation in an age mouse model during administration of rhlGF-I on new bone formation in an aged mouse model during distraction osteogenesis. J Bone Miner Res. 2005.
    62. Wahl, EC, Aronson, J, Skinner, RA, Lumpkin CK. BrdU tracking of preosteoblasts in formalin fixed, decalcified regenerating bone. J Bone Miner Res. 2005.
    63. Ronis, MJJ, Badger, TM, Lumpkin CK, Aronson, J, Hidestrand, M, Shankar, K, Haley, R. Mechanisms of ethanol-induced bone loss differ with physiological state. The Toxicologist. 2005; 211.
    64. Ronis MJJ, Badger TM, Lumpkin CK, Aronson J, Hidestrand M, Shankar K, Haley R. Mechanisms of ethanol-induced bone loss differ with physiological state. The Toxicologist. 2005; 84:211.
    65. Thrailkill, KM, Wahl, EC, Liu, L, Cockrell, GE, Bunn, RC, Perrien, DS, Fowlkes, JL, Skinner, RA, Aronson, J, Lumpkin CK. Insulin replacement in T1DM restores new bone formation despite persistent hyperglycemia. 87th Endocrine Society. 2005.
    66. Haley R, Hidestrand M, Shankar K, Lumpkin CK, Yarberry B, Ronis MJJ. Estradiol protects against ethanol-induced bone loss in female rats by preventing osteoclast activation. The Toxicologist. 2005; 84:354.
    67. Perrien DS, Wahl EC, Hogue WR, Feige U, Aronson J, Ronis MJ, Badger TM, Lumpkin CK. IL-1 and TNF antagonists prevent inhibition of fracture healing by ethanol in rats. Toxicol Sci. 2004 Dec; 82(2):656-60. PMID: 15470231.
      View in: PubMed
    68. Wahl EC, Liu L, Perrien DS, Aronson J, Hogue WR, Skinner RA, M Hidestrand, Ronis MJJ, Badger TM, Lumpkin CK. Inhibition of direct bone formation associated with chronic ethanol exposure in a mouse model of distraction osteogenesis. The Toxicologist. 2004; 78:A1365.
    69. Liu L, Aronson J, Wahl EC, Skinner RA, Fowlkes BG, Badger TM, Lumpkin CK. Direct bone formation in Nude (Nu/Nu) mice. The Toxicologist. 2004; 78:A1362.
    70. Mats Hidestrand, Kartik Shankar, James Aronson, Thomas Badger, Lumpkin CK, Martin Ronis. Ethanol inhibits the anabolic rebuilding of bone following pregnancy and lactation in rats fed via total enteral nutrition (TEN). Proc. Endocrine Soc. Meeting P2-271. 2004; 371-2.
    71. Ronis MJJ, Hidestrand M, Shankar K, Lumpkin CK, Badger TM, Aronson J, Skinner RA, Hogue W, Jo CH, Simpson P, Zipperman M, Haley R, Humphrey L. Pregnancy alters the mechanism of alcohol-induced bone loss in female rats. The Toxicologist. 2004; 78:A1361.
    72. Aronson J, Liu L, Wahl EC, Perrien DS, Skinner RA, Badger TM, Lumpkin CK. Administration of rmTNF-a Inhibits Endosteal Bone Formation in a Mouse Distraction Osteogenesis Model. The Toxicologist. 2004; 78:A1363.
    73. Perrien DS, Liu Z, Wahl EC, Bunn RC, Skinner RA, Aronson J, Fowlkes J, Badger TM, Lumpkin CK. Chronic ethanol exposure is associated with a local increase in TNF-alpha and decreased proliferation in the rat distraction gap. Cytokine. 2003 Sep 21; 23(6):179-89. PMID: 12967643.
      View in: PubMed
    74. Perrien DS, Montague DC, Akel NS, Suva LJ, Lumpkin CK, Aronson J, Gaddy D. Acute nicotine exposure impairs the early period of fracture healing but enhances osteogenesis in bone marrow cultures through a BMP-independent pathway. UAMS Research Week. 2003.
    75. Aronson J, Liu L, Liu Z, Gao GG, Perrien DS, Wahl EC, Miller F, Montague D, Skinner RA, Lumpkin CK. The efficacy of different delivery systems for FGF-2 to treat age-related inhibition of bone formation during distraction osteogenesis in the rat tibial lengthening model. Trans 49th Ortho Res Soc. 2003.
    76. Aronson J, Liu Z, Wahl EC, Liu L, Perrien DS, Kern PA, Fowlkes JL, Thrailkill KM, Bunn RC, Suva LJ, Skinner RA, Lumpkin CK. Impaired bone formation during distraction osteogenesis in ZDF rats. J Bone Miner Res. 2003; 18(S2):S281.
    77. Thrailkill KM, Liu L, Wahl EC, Liu Z, Bunn RC, Hogue W, Suva LJ, Perrien DS, Fowlkes JL, Aronson J, Lumpkin CK. New bone formation is impaired in a model of Type 1 Diabetes Mellitus. J Bone Miner Res. 2003; 18(S2):S169.
    78. Ronis MJ, Badger TM, Lumpkin CK, Haley R, Zipperman M, Gardner B, Ferguson M, Hale K, Dallari T. Alcohol-induced bone loss in pregnancy is associated with inhibited bone formation and disrupted calcium homeostasis. Alc. Clin. Exp. Res. 2003; 27:60A.
    79. Aronson J, Liu Z, Wahl EC, Liu L, Perrien DS, Kern PA, Fowlkes JL, Thrailkill KM, Bunn RC, Suva LJ, Skinner RA, Lumpkin CK. The effects of rhFGF2/sTNF-R1 on bone formation during distraction osteogenesis in ZDF rats. J Bone Miner Res. 2003; 18(S2):S330.
    80. Perrien DS, Brown EC, Fletcher TW, Irby DJ, Aronson J, Gao GG, Skinner RA, Hogue WR, Feige U, Suva LJ, Ronis MJ, Badger TM, Lumpkin CK. Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis. J Pharmacol Exp Ther. 2002 Dec; 303(3):904-8. PMID: 12438508.
      View in: PubMed
    81. Brown EC, Perrien DS, Fletcher TW, Irby DJ, Aronson J, Gao GG, Hogue WJ, Skinner RA, Suva LJ, Ronis MJ, Hakkak R, Badger TM, Lumpkin CK. Skeletal toxicity associated with chronic ethanol exposure in a rat model using total enteral nutrition. J Pharmacol Exp Ther. 2002 Jun; 301(3):1132-8. PMID: 12023547.
      View in: PubMed
    82. Perrien DS, Brown EC, Aronson J, Skinner RA, Montague DC, Badger TM, Lumpkin CK. Immunohistochemical study of osteopontin expression during distraction osteogenesis in the rat. J Histochem Cytochem. 2002 Apr; 50(4):567-74. PMID: 11897810.
      View in: PubMed
    83. Lumpkin CK, Aronson J, Gao GG, Brown EC, Perrien DS, Hogue WR, Skinner RA, Badger TM. Chronic ethanol effects on rat bone strength and regeneration. Toxicologist. 2001; 60(S):388.
    84. Aronson J, Liu L, Shin H, Saylors R, Lumpkin CK. Endosteal bone formation in relation to local bone marrow constituents in the rat model of distraction osteogenesis. 2001; Trans 47th Ortho Res Soc.
    85. Aronson J, Liu L, Liu Z, Gao GG, Perrien DS, Skinner RA, Morris KD, Suva LJ, Lumpkin CK. Decreased bone formation accompanies aging in a mouse model of distraction osteogenesis. J Bone Miner Res. 2001; 16(suppl 1):S329.
    86. Aronson J, Gao GG, Shen X, Miller F, Montague DC, Skinner RA, Abraham J, Badger TM, Lumpkin CK. The effects of local extraperiosteal administration of rhFGF-2 on distraction osteogenesis in the aged rat model. Ortho Res Soc. 2000; 25:730.
    87. Aronson J, Gao GG, Shen X, SG McLaren, Skinner RA, Badger TM, Lumpkin CK. Distraction osteogenesis in the aging rat. Assoc Bone Joint Surgeons. 1999.
    88. Ronis MJJ, Rector C, Badger TM, Hogue W, Aronson J, Lumpkin CK. Effects of sex steroid replacement and I-dopa treatment on lead toxicity in the developing rat. Toxicologist. 1999; 48(S):327.
    89. Aronson J, Gao GG, Shen X, SG McLaren, Skinner RA, Badger TM, Lumpkin CK. Aging and distraction osteogenesis in the rat. Ped Ortho Soc N Amer. 1999.
    90. Aronson J, Gao GG, Shen X, Miller F, Montague DC, Skinner RA, Abraham J, Badger TM, Lumpkin CK. A role for FGF-2 during distraction osteogenesis in young and old rats. Trans 44th Orthop Res Soc. 1998; 23:600.
    91. Ronis MJJ, Rector C, Badger TM, Gao GG, Aronson J, Lumpkin CK. Effects of lead on bone strength and osteoblastic bone formation in the rat. Soc Toxicology. 1998.
    92. Lumpkin CK, Aronson J, Gao GG, Skinner RA, Badger TM. Chronic ethanol's effects on rat bone strength and regeneration. Res Soc Alcoholism. 1998.
    93. Aronson J, Hogue WR, Flahiff CM, Shen X, Gao GG, Skinner RA, Badger TM, Lumpkin CK. Development of tensile strength during distraction and consolidation in a rat model of osteogenesis. Orthopaedic Res Soc. 1997.
    94. Aronson J, Shen X, Gao GG, Miller F, Quattlebaum T, Skinner RA, Badger TM, Lumpkin CK. Proliferation patterns in a rat model of distraction osteogenesis. Orthopaedic Res Soc. 1996.
    95. Aronson J, Shen XC, Gao GG, Badger TM, Lumpkin CK. A rat external fixation model for limb lengthening. Invited abstract for 9th Gordon Research Conference on Bioengineering and Orthopaedic Science. 1996.
    96. Aronson J, Gao GG, Shen X, SG Hickmon, Skinner RA, Badger TM, Lumpkin CK. Effect of aging on distraction osteogenesis in the rat. J Bone Miner Res. 1996; 11(supple 1):S321.
    97. Shen XC, Aronson J, Hollis JM, Lumpkin CK. Mechanical properties and bone mineral levels of regenerate bone in a rat model of tibial lengthening. Orthpaedic Res Soc. 1995.
    98. Aronson J, Shen XC, Irby DJ, Skinner RA, Dixon DC, Wilcox TL, Hakkak R, Puskarich-May C, Badger TM, Lumpkin CK. The effects of total enteral nutrition on distraction osteogenesis in a rat model. Orthopaedic Res Soc. 1995.
    99. Lumpkin CK, Henle KJ, Nolen GT, Walker PD, Nagle WA. Effects of antisense inhibition on GP50/J6 in Chinese hamster ovary cells. Radiation Res Soc. 1994.
    100. Goldstein S, Thweatt R, Lumpkin CK, Liu S. Senescence and over expression of a novel gene decreases whole-cell calcium-dependent current. Amer Fed Clin Res. 1993.
    101. Henle KJ, Wang SY, Nolen GT, Johnson VA, Lumpkin CK. Probable identity of the heat stress-induced glycoprotein, GP 50, and the retinoic acid-inducible J6 gene product. Radiation Res Soc. 1993.
    102. Badger, TM, Ronis, MJJ, Lumpkin CK. NIAAA Monograph on Alcohol and Endocrine System. The effects of alcohol on growth hormone and growth hormone-regulated systems. 1993; 17.
    103. Schlenk D, Ronis MJJ, Lumpkin CK, McClure G, Hinson J, Badger T. An integrated approach of biomonitoring fresh water environments. Toxicologist. 1993; 13:186.
    104. Bannon GA, West CM, Quirk JG, Lumpkin CK, Fendrick JL, O'Brien TJ. Prohibitin, a tumor suppressor gene that may be involved in the development of ovarian cancer. Int Meeting Gynaecological Oncology. 1993.
    105. Badger TM, Ronis MJJ, Lumpkin CK, Valentine C, Irby D, Huang J, Mercado C, Shahare M, Crouch J. The effects of chronic slcohol on growth hormone, luteinizing hormone, testosterone and growth hormone regulated systems in the male rat. Ninth Int Congress Endo. 1992.
    106. Crouch J, Irby D, Lumpkin CK, Badger TM. Blood and urine alcohol levels are episodoic in rats receiving continuous intragastric ethanol infusions. Alcoholism Clin Exp Res. 1992; 16:370.
    107. Lumpkin CK, Moore TL, Tarpley MD, Taylor JM, Badger TM, McClung JK. The effects of acute ethanol on growth suppressor transcripts during compensatory growth in rat liver. Alcoholism Clin Exp Res. 1992; 16:364.
    108. Badger TM, Ronis MJJ, Lumpkin CK, Valentine C, Hakkak R, Huang J, Irby D. Gonadal factors and ethanol's actions on hepatic drug metabolism: effects on cytochrome P450 cyp 2C11. CPDD Symp. 1991.
    109. Ronis MJJ, Lumpkin CK, ElDeib M, Hakkak R, Valentine C, Ingelman Sundberg M, Thomas PE, Badger TM. Induction and supression of rat hepatic microsomal cytochrome P450 isozomes by chronic ethanol treatment in a system utilizing total enteral nutrition. Toxicologist. 1991; 11:302.
    110. Badger TM, Ronis MJJ, Lumpkin CK, Ingelman-Sundberg M, Shahare M, Mercado C, Huang J, Irby D, Crouch J. Effects of short term alcohol on the hepatic microsomal monooxygenase system in rats receiving nutrition sufficient to promote normal weight gains. FASEB J. 1991; 5:A1451.
    111. Badger TM, Ronis MJJ, Lumpkin CK, Ingelman-Sundberg M, Huang J, El Deib M, Shahare M, Irby D, Mercado C, Crouch J. Diet and cytochrome P450j: Isozome activity and apoprotein level during chronic alcohol exposure. Alcohol Clin Exp Res. 1991; 15:353.
    112. Lumpkin CK, Taylor JM, McClung JK, Badger TM. Acute ethanol and hepatic regeneration: c-myc transcripts. Alcoholism Clin Exp Res. 1991; 15:344.
    113. Lumpkin CK, Ronis MJJ, Badger TM. The microsomal monooxygenase system of regenerating liver. Toxicologist. 1990; 10:46.
    114. Ronis MJJ, Lumpkin CK, Johansson A, Ingelman Sundberg M, Badger TM. Cytochrome P-450Etoh2: A putative ethanol inducible member of P450 gene family IIC under different regulation than P450 IIEI. Proc VIIIth Symp Microsomes and Drug Oxidation. 1990; 92.
    115. Ronis MJJ, Lumpkin CK, Badger TM. The effect of short term ethanol treatment on hepatic microsomal monooxygenase(HMO) in a system utilizing total enteral nutrition(TEN). Toxicologist. 1990; 10:46.
    116. Lumpkin CK, Henle KJ, Norris JS, Nolen GT. Expression of thermotolerance in CHO cells following microinjection of polyA RNA from thermotolerant cells. Radiation Res Soc Abs. 1989; 55.
    117. Rossby SP, Lumpkin CK, Taylor JM, McGehee RE Jr, Cornett LE. Steady state levels of alpha one adrenergic receptor mRNA in the regenerating rat liver. Endocrine Soc Abs. 1989; 71st: 40.
    118. Lumpkin CK, Henle KJ. Thermotolerance development following microinjection or electroporation of glutathione disulfide. Fed Proc. 1988; 44:855.
    119. Lumpkin CK, McClung JK, Smith JR. Microinjection of rat liver mRNA modulates DNA synthesis in human fibroblasts. In Vitro. 1985; 21:27A.
    120. Pereira Smith OM, Lumpkin CK, Knepper J, Butel JS, Smith JR. The recessive nature of cellular immortality: further evidence. J Cell Biol. 1985; 101:484A.
    121. Lumpkin CK, McGill, JR, Riabowol, KT, Moerman, EJ, Shmookler, Reis RJ, Goldstein, S. Werner's Syndrome and Human Aging. Extrachromosomal circular DNA and aging cells. 1985; 479.
    122. McClung JK, Lumpkin CK, Smith JR. Modulation of DNA synthesis in human fibroblasts by microinjection of rat liver mRNA. Fed Proc. 1985; 44:855.
    123. Smith JR, Pereira Smith OM, Lumpkin CK, McClung JK. Inhibiters of DNA synthesis from senescent and quiescent human fibroblasts. J Cell Biol. 1985; 101:141A.
    124. McClung JK, Lumpkin CK, Smith JR. Inhibition of DNA synthesis by microinjection of mRNA isolated from senescent and quiescent human fibroblasts. In Vitro. 1985; 21:19A.
    125. Shmookler, Reis RJ, Lumpkin CK, McGill, JR, Riabowol, KT, Goldstein, S. Cold Spring Harbor Symposium on Quanitative Biology XLVII. Structure of DNA. Genome alternation during in vitro and vivo aging: Amplification of extrachromosomal circular DNA molecules containing a chromosomal sequence of variable repeat frequency. 1983; 1135.
    126. Shmookler Reis RJ, Lumpkin CK, McGill JR, Riabowol KT, Goldstein, S. Amplification of an inter-alu sequence in extrachromosomal DNA circles during in vivo and in vitro aging of normal human cells. In Vitro. 1983; 19:282.
    127. Goldstein S, Lumpkin CK, Riabowol KT, Shmookler Reis RJ. Human aging in vitro and in vivo: Amplification of extrachromosomal circular copies of an inter-alu unstable DNA sequence. Clin Res. 1983; 478A.
    128. Lumpkin CK, Smith, JR. The induction by mitotic inhibitors of micronucleation in human cells. In Vitro. 1980; 16:229.
    129. Lumpkin CK. Dissertation. A Multivariate craniometric analysis of selected Southwestern population. 1976.
    Lumpkin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _